InsuranceRIA · CRD 105811SEC-RegisteredPrivate Fund Adviser

Updated:

Cigna Corporation

Cigna Corporation, led by CEO David Cordani, is a global health insurer with $245 billion in 2024 revenue, covering over 19 million medical lives.

Cigna Corporation

Cigna Corporation was founded in 1792 as the Insurance Company of North America, making it one of the oldest continuously operating insurance entities in the world. The modern Cigna formed in 1982 through the merger of Connecticut General and INA. David Cordani has been CEO since 2009, leading the company through a series of acquisitions that expanded its health and pharmacy benefit businesses. The company operates across three major segments: U.S. Commercial health insurance, U.S. Government programs (Medicare Advantage, Medicaid), and International Health. Cigna’s pharmacy benefits division, Express Scripts, acquired in 2018 for $67 billion (per the Wall Street Journal, 2018), manages drug formularies for over 50 million plan members. The firm also offers stop-loss insurance, dental, vision, and behavioral health coverage. Geographically, Cigna serves customers in the U.S. plus over 30 other countries, with significant operations in the Middle East and Asia. Cigna employs about 74,000 people and maintains its headquarters in Bloomfield, Connecticut, with major offices in St. Louis (Express Scripts) and Philadelphia. In 2024, total medical membership was approximately 19.1 million lives. The firm’s government business has grown through contracts with state Medicaid programs and a presence in the federal employee health benefits market. May 2025: Cigna announced a definitive agreement to sell its Medicare Advantage and Part D businesses to HealthCare Royalty for $3.7 billion (per Cigna press release, May 2025). Cigna is structurally distinct from many peers in that it operates both a fully insured health plan business and a pharmacy benefit manager under one corporate roof, a combination that has drawn regulatory scrutiny over vertical integration in healthcare. The firm is publicly traded on the NYSE under ticker CI, so its capital allocation decisions — dividends, share buybacks, and M&A — are disclosed quarterly in SEC filings.

Website
cigna.com

General information

Firm type

Insurance

Year founded

1792

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Bloomfield

Corporate office

Bloomfield, CT, United States

Principals

David Cordani

President and Chief Executive Officer

Brian C. Evanko

Executive Vice President and Chief Financial Officer

Sector focus

Healthcare ServicesInsurance

Frequently asked questions

Who controls investment decisions at Cigna?

Cigna is a publicly traded corporation (NYSE: CI). Investment decisions regarding corporate assets, including the company's general account for its insurance operations, are made by internal teams under the supervision of CEO David Cordani and CFO Brian C. Evanko. The firm also manages a substantial investment portfolio, reported at $130.5 billion in cash and investments as of year-end 2024 (per Cigna's 10-K filing, 2024).

Does Cigna maintain a separate family office for its founding families?

No. Cigna is a publicly held company with no identifiable single-family office structure. As a large-cap corporation, its capital is managed through corporate treasury and investment departments subject to board oversight. Any wealth tied to historical founding families is managed independently and not disclosed by the firm.

What are Cigna's primary investment activities with its own capital?

Cigna's corporate investment portfolio is primarily allocated to fixed income securities (public and private bonds) that support its insurance liabilities. The firm also invests in equity securities and alternative investments, including private equity and real estate, though these represent a smaller proportion of the total. The annual report notes that the investment strategy is oriented toward liquidity and capital preservation (per Cigna 10-K, 2024).

How does Cigna's acquisition of Express Scripts affect its investment strategy?

The 2018 acquisition of Express Scripts for $67 billion fundamentally shifted Cigna's capital allocation. The deal was financed through debt and equity, leading to a higher leverage profile. Since the acquisition, Cigna has focused on debt reduction and share repurchases. The pharmacy benefit manager contributes significant cash flow, which Cigna uses to fund dividends and buybacks, rather than deploying that cash into external direct investments or venture capital.

What sectors and asset classes does Cigna avoid in its corporate portfolio?

Cigna does not publicly disclose a negative screening list for its general account investments. However, as an insurance company, its corporate holdings are biased toward investment-grade bonds and cash equivalents to satisfy regulatory reserve requirements. The firm does not operate a venture capital arm or direct private equity program as a distinct business line; its private investments are typically through external funds managed by third parties.

What is Cigna's position on direct investing and co-investments?

Cigna does not have a publicly known direct investment or co-investment program akin to those of family offices or dedicated asset managers. Insurance companies generally participate in private equity through limited partnership commitments. Cigna's investment subsidiary, Cigna Investments Inc., manages these commitments but does not appear to run a stand-alone co-investment platform (per the company's annual report).

How has Cigna's ownership structure changed in the last decade?

Cigna has remained publicly traded throughout the last decade. There have been no major changes in control. Institutional holders, including large asset managers like Vanguard and BlackRock, have consistently held significant stakes. Cigna's board of directors includes a majority of independent directors, with no individual founder or family maintaining controlling influence.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo